SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,397 | -53.9% | 7,330 | 0.0% | 0.00% | – |
| Q2 2023 | $9,529 | -26.1% | 7,330 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $12,901 | -48.7% | 7,330 | -8.5% | 0.00% | 0.0% |
| Q4 2022 | $25,167 | -15.6% | 8,015 | +31.7% | 0.00% | 0.0% |
| Q3 2022 | $29,826 | -10.7% | 6,087 | -24.6% | 0.00% | 0.0% |
| Q2 2022 | $33,406 | -28.7% | 8,069 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $46,881 | -79.3% | 8,069 | -73.3% | 0.00% | -33.3% |
| Q4 2021 | $226,350 | -29.9% | 30,180 | -15.8% | 0.00% | -40.0% |
| Q3 2021 | $322,990 | -24.7% | 35,848 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $429,101 | +4.3% | 35,848 | +9.2% | 0.01% | 0.0% |
| Q1 2021 | $411,347 | -24.7% | 32,829 | -6.2% | 0.01% | -25.0% |
| Q4 2020 | $546,347 | +65.1% | 35,011 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $330,854 | +4.0% | 35,011 | -1.4% | 0.01% | 0.0% |
| Q2 2020 | $318,268 | +55.5% | 35,521 | +10.5% | 0.01% | +50.0% |
| Q1 2020 | $204,687 | -33.3% | 32,133 | -12.3% | 0.00% | -20.0% |
| Q4 2019 | $306,677 | -11.5% | 36,640 | -4.3% | 0.01% | -16.7% |
| Q3 2019 | $346,543 | -6.4% | 38,292 | +11.4% | 0.01% | 0.0% |
| Q2 2019 | $370,057 | +22.2% | 34,360 | +8.3% | 0.01% | +20.0% |
| Q1 2019 | $302,752 | -20.8% | 31,735 | -4.7% | 0.01% | -37.5% |
| Q4 2018 | $382,307 | -32.3% | 33,302 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $564,469 | -99.9% | 33,302 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $472,889,000 | -8.6% | 33,302 | +22.2% | 0.01% | +14.3% |
| Q1 2018 | $517,598,000 | +120271.6% | 27,242 | +4.0% | 0.01% | +16.7% |
| Q4 2017 | $430,000 | -48.9% | 26,203 | -53.3% | 0.01% | +20.0% |
| Q3 2017 | $841,000 | +97.9% | 56,091 | +16.1% | 0.01% | +66.7% |
| Q2 2017 | $425,000 | +69.3% | 48,332 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $251,000 | +65.1% | 48,332 | -2.8% | 0.00% | +100.0% |
| Q4 2016 | $152,000 | -33.0% | 49,713 | +1.6% | 0.00% | -50.0% |
| Q3 2016 | $227,000 | -18.1% | 48,933 | +2.2% | 0.00% | 0.0% |
| Q2 2016 | $277,000 | -4.5% | 47,865 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $290,000 | -33.6% | 47,865 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $437,000 | +61.9% | 47,865 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $270,000 | -49.7% | 47,865 | -1.2% | 0.00% | -50.0% |
| Q2 2015 | $537,000 | -31.8% | 48,439 | -3.4% | 0.00% | -33.3% |
| Q1 2015 | $787,000 | +3.1% | 50,164 | 0.0% | 0.01% | +20.0% |
| Q4 2014 | $763,000 | +41.0% | 50,164 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $541,000 | -37.5% | 50,164 | -11.4% | 0.00% | -33.3% |
| Q2 2014 | $865,000 | -4.2% | 56,649 | +13.4% | 0.01% | 0.0% |
| Q1 2014 | $903,000 | +16.4% | 49,965 | -10.6% | 0.01% | +20.0% |
| Q4 2013 | $776,000 | +58.7% | 55,902 | +19.9% | 0.01% | +25.0% |
| Q3 2013 | $489,000 | +43.8% | 46,642 | +7.1% | 0.00% | +33.3% |
| Q2 2013 | $340,000 | – | 43,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |